219 related articles for article (PubMed ID: 31834298)
1. [Role of multimodality imaging in the clinical evaluation of hypertrophic cardiomyopathy].
Guido V; Campana M; Pino PG; Moreo A; De Chiara B; Bertella E; Khoury G;
G Ital Cardiol (Rome); 2019 Dec; 20(12):746-761. PubMed ID: 31834298
[TBL] [Abstract][Full Text] [Related]
2. Multiple myocardial crypts: multimodality imaging evaluation.
Gonçalves Almeida J; Ladeiras-Lopes R; Bettencourt N; Ferreira N; Ribeiro J; Gama Ribeiro V
Echocardiography; 2016 Oct; 33(10):1617-1618. PubMed ID: 27357905
[TBL] [Abstract][Full Text] [Related]
3. Multimodality imaging of hypertrophic cardiomyopathy.
Dong T; Gilliland Y; Kramer CM; Theodore A; Desai M
Prog Cardiovasc Dis; 2023; 80():14-24. PubMed ID: 37586654
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin amyloidosis in a septuagenarian masquerading as hypertrophic cardiomyopathy: the importance of multimodality imaging.
Chawla D; Cheema O; Jan MF; Tajik AJ
Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):328. PubMed ID: 29272373
[No Abstract] [Full Text] [Related]
5. Cor triatriatum and hypertrophic cardiomyopathy.
Pellaton C; O'Mahony C; Ludman AJ; Sekhri N; Mohiddin S
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e141-e143. PubMed ID: 25000250
[TBL] [Abstract][Full Text] [Related]
6. Integrated Imaging in Hypertrophic Cardiomyopathy.
Choudhury L; Rigolin VH; Bonow RO
Am J Cardiol; 2017 Jan; 119(2):328-339. PubMed ID: 27816114
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Multimodality Imaging in Hypertrophic Cardiomyopathy: What to Look for and When to Image.
Wengrofsky P; Akivis Y; Bukharovich I
Curr Cardiol Rev; 2023; 19(5):1-18. PubMed ID: 36927425
[TBL] [Abstract][Full Text] [Related]
8. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging.
Kherada N; Vinardell JM; Mihos CG; Santana O
Echocardiography; 2017 Sep; 34(9):1392-1395. PubMed ID: 28573739
[TBL] [Abstract][Full Text] [Related]
9. Positrons, protons, and pulse waves: Multimodality characterization of newly diagnosed hypertrophic cardiomyopathy.
Al-Sabeq B; Soliman A; Chamsi-Pasha M; Shah DJ; Al-Mallah M
J Nucl Cardiol; 2020 Dec; 27(6):2412-2416. PubMed ID: 31898000
[No Abstract] [Full Text] [Related]
10. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.
Cardim N; Galderisi M; Edvardsen T; Plein S; Popescu BA; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Freitas A; Habib G; Kitsiou A; Petersen SE; Schroeder S; Lancellotti P; Camici P; Dulgheru R; Hagendorff A; Lombardi M; Muraru D; Sicari R
Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):280. PubMed ID: 25650407
[TBL] [Abstract][Full Text] [Related]
11. Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification.
Tower-Rader A; Kramer CM; Neubauer S; Nagueh SF; Desai MY
Circ Cardiovasc Imaging; 2020 Feb; 13(2):e009026. PubMed ID: 32063056
[TBL] [Abstract][Full Text] [Related]
12. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques.
Luckie M; Khattar RS
Minerva Cardioangiol; 2011 Dec; 59(6):581-9. PubMed ID: 22134470
[TBL] [Abstract][Full Text] [Related]
13. The role of echocardiography in hypertrophic cardiomyopathy.
Williams LK; Gruner CH; Rakowski H
Curr Cardiol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618305
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of apical hypertrophic cardiomyopathy and apical displacement of the papillary muscles: a multimodality imaging point of view.
Ünlü S; Özden Tok Ö; Avcı Demir F; Papadopoulos K; Monaghan MJ
Echocardiography; 2021 Jan; 38(1):103-113. PubMed ID: 33067903
[TBL] [Abstract][Full Text] [Related]
15. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
[TBL] [Abstract][Full Text] [Related]
16. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
Bogaert J; Olivotto I
Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269
[TBL] [Abstract][Full Text] [Related]
17. Severe Late-Onset Fabry Cardiomyopathy Unmasked by a Multimodality Imaging Approach.
Visoiu IS; Ciobanu AO; Nicula AI; Iascone M; Jurcut R; Vinereanu D; Rimbas RC
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009709. PubMed ID: 31630529
[No Abstract] [Full Text] [Related]
18. Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management.
Phelan D; Sperry BW; Thavendiranathan P; Collier P; Popović ZB; Lever HM; Smedira NG; Desai MY
Am J Cardiol; 2017 May; 119(10):1656-1662. PubMed ID: 28363351
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
20. [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part I].
Pleva M; Borová J; Plevová I; Januška J; Belicová M
Vnitr Lek; 2017; 63(3):194-198. PubMed ID: 28379022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
